Innovent Biologics, Inc.

SEHK:1801 Stock Report

Market Cap: HK$77.9b

Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:1801 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 25SellHK$176,018,766SDIC Innovation Investment Management Co., Ltd.Company3,760,000HK$46.81
21 Mar 25SellHK$96,203,961Capital Research and Management CompanyCompany2,343,500HK$41.05
19 Feb 25SellHK$83,482,099JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,174,987HK$38.38
17 Feb 25BuyHK$47,103,769JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,218,824HK$38.65
21 Jan 25SellHK$17,869,097JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany570,089HK$31.34
20 Jan 25SellHK$104,969,303Capital Research and Management CompanyCompany3,327,405HK$31.55
16 Jan 25BuyHK$147,583,853JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,781,624HK$30.86
16 Jan 25SellHK$1,250,024JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany40,500HK$30.86
15 Jan 25BuyHK$3,675,796JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany108,500HK$33.88
15 Jan 25BuyHK$50,817JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany1,500HK$33.88
15 Jan 25SellHK$69,539,453JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,052,625HK$33.88
07 Jan 25BuyHK$9,619,225SDIC Innovation Investment Management Co., Ltd.Company275,000HK$34.98
05 Dec 24SellHK$30,150,656JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany803,621HK$37.52
30 Oct 24SellHK$308,323,657JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany8,668,935HK$35.57
29 Oct 24BuyHK$173,805,835JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,592,813HK$37.84
10 Oct 24SellHK$533,963,168JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,891,140HK$49.03
08 Oct 24BuyHK$548,077,815JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,412,177HK$48.03
02 Oct 24SellHK$81,170,776De-Chao YuIndividual1,750,000HK$46.72
30 Sep 24SellHK$70,584,004De-Chao YuIndividual1,500,000HK$47.37
27 Sep 24SellHK$33,657,461Hao Xi EdeIndividual736,500HK$45.70
26 Sep 24SellHK$3,651,200Hao Xi EdeIndividual81,500HK$44.80
11 Sep 24BuyHK$86,095JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,000HK$43.05
11 Sep 24BuyHK$86,095JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany2,000HK$43.05
11 Sep 24SellHK$1,743,432JP Morgan Asset ManagementCompany40,500HK$43.05
11 Sep 24SellHK$666,472,087JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany15,482,177HK$43.05
10 Sep 24BuyHK$448,670,085JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,624,087HK$42.23
10 Jul 24SellHK$99,421,894Capital Research and Management CompanyCompany2,755,000HK$36.09
03 May 24SellHK$36,587,668De-Chao YuIndividual906,250HK$40.37

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1801?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,614,5000.648%
VC/PE Firms84,010,8505.13%
Individual Insiders111,033,6936.78%
Institutions659,566,23340.3%
General Public772,962,22847.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 42.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.55%
De-Chao Yu
107,375,525HK$5.1b0.35%no data
5.13%
SDIC Innovation Investment Management Co., Ltd.
84,010,850HK$4.0b-6.11%27.36%
4.96%
Capital Research and Management Company
81,221,143HK$3.9b-28.4%0.02%
3.63%
The Vanguard Group, Inc.
59,492,727HK$2.8b1.01%0.01%
2.87%
BlackRock, Inc.
47,095,742HK$2.2b2.77%no data
2.22%
GF Fund Management Co., Ltd.
36,440,000HK$1.7b0%0.46%
2.2%
Temasek Holdings (Private) Limited
35,965,000HK$1.7b20.9%0.17%
1.98%
Norges Bank Investment Management
32,441,094HK$1.5b0%0.02%
1.52%
Citigroup Inc.,Banking and Securities Investments
24,932,063HK$1.2b0%0.12%
1.46%
Bosera Asset Management Co., Ltd.
23,965,000HK$1.1b0%0.63%
1.44%
Fidelity International Ltd
23,657,504HK$1.1b-29%0.06%
1.43%
Harvest Fund Management Co. Ltd.
23,397,288HK$1.1b0%0.3%
1.14%
E Fund Management Co., Ltd.
18,603,000HK$884.3m0%0.12%
0.76%
Schroder Investment Management Limited
12,378,500HK$588.4m0%0.05%
0.69%
China Asset Management Co. Ltd.
11,244,649HK$534.5m-5.86%0.07%
0.63%
FMR LLC
10,276,691HK$488.5m-12.5%no data
0.62%
Schroder Investment Management North America Inc.
10,236,500HK$486.6m5.05%0.2%
0.6%
Polar Capital Holdings Plc
9,878,635HK$469.6m0.45%0.23%
0.51%
ICBC Credit Suisse Asset Management Co., Ltd.
8,343,974HK$396.7m0%0.26%
0.45%
Schroder Investment Management (Hong Kong) Ltd.
7,410,000HK$352.3m0%0.26%
0.41%
Fullerton (Private) Limited
6,673,500HK$317.2m0%no data
0.38%
AEGON-Industrial Fund Management Co. Ltd.
6,188,858HK$294.2m0%0.23%
0.37%
Bank of China Investment Management Co., Ltd.
6,134,000HK$291.6m0%0.88%
0.36%
Geode Capital Management, LLC
5,932,906HK$282.0m0.91%no data
0.36%
UBS Asset Management AG
5,906,709HK$280.8m3.13%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/18 10:44
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Innovent Biologics, Inc. is covered by 56 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Shun Kei LawCCB International Securities Limited
Zhishun SiuCCB International Securities Limited